Eckard Jonathan 4
4 · TYME TECHNOLOGIES, INC. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
Eckard Jonathan
Director
Transactions
- Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−150,000→ 0 totalExercise: $2.90Exp: 2023-11-07→ Common Stock (150,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−500,000→ 0 totalExercise: $4.31Exp: 2028-03-22→ Common Stock (500,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−370,700→ 0 totalExercise: $1.56Exp: 2030-05-06→ Common Stock (370,700 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−150,000→ 0 totalExercise: $2.90Exp: 2029-05-02→ Common Stock (150,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−300,000→ 0 totalExercise: $1.39Exp: 2032-04-21→ Common Stock (300,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−431,000→ 0 totalExercise: $1.43Exp: 2032-04-21→ Common Stock (431,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−482,200→ 0 totalExercise: $0.32Exp: 2032-04-21→ Common Stock (482,200 underlying)
Footnotes (7)
- [F1]This option was fully vested and assumed by Syros Pharmaceuticals, Inc. ("Syros") in its merger with the issuer and replaced with an option to purchase 21,910 shares of Syros common stock for $98.36 per share, after giving effect to a 1-for-10 reverse stock split by Syros (the "Reverse Split").
- [F2]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 6,573 shares of Syros common stock for $66.18 per share, after giving effect to the Reverse Split.
- [F3]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 6,573 shares of Syros common stock for $66.18 per share, after giving effect to the Reverse Split.
- [F4]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 16,244 shares of Syros common stock for $35.60 per share, after giving effect to the Reverse Split.
- [F5]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 13,146 shares of Syros common stock for $31.72 per share, after giving effect to the Reverse Split.
- [F6]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 18,886 shares of Syros common stock for $32.63 per share, after giving effect to the Reverse Split.
- [F7]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,130 shares of Syros common stock for $7.30 per share, after giving effect to the Reverse Split.